AstraZeneca and Lilly’s Alzheimer’s drug fails trial
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
Early findings from a phase 3 clinical trial report promising results
The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for…
Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
U.S. regulatory submission for patients ages 12-17 planned for third quarter 2018 A pivotal Phase 3 trial evaluating Dupixent® (dupilumab)…